B. Zeng Et Al. , "Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats," NEUROSCIENCE LETTERS , vol.276, no.2, pp.71-74, 1999
Zeng, B. Et Al. 1999. Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats. NEUROSCIENCE LETTERS , vol.276, no.2 , 71-74.
Zeng, B., Dass, B., Owen, A., Rose, S., Cannizzaro, C., Tel, B. C., ... Jenner, P.(1999). Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats. NEUROSCIENCE LETTERS , vol.276, no.2, 71-74.
Zeng, BY Et Al. "Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats," NEUROSCIENCE LETTERS , vol.276, no.2, 71-74, 1999
Zeng, BY Et Al. "Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats." NEUROSCIENCE LETTERS , vol.276, no.2, pp.71-74, 1999
Zeng, B. Et Al. (1999) . "Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats." NEUROSCIENCE LETTERS , vol.276, no.2, pp.71-74.
@article{article, author={BY Zeng Et Al. }, title={Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats}, journal={NEUROSCIENCE LETTERS}, year=1999, pages={71-74} }